CrossBridge Bio
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $11M
Investors
- 5
About CrossBridge Bio
Founded in 2023 and based in Texas, US, CrossBridge Bio, Inc. focuses on advancing cancer treatments by developing antibody-drug conjugates (ADCs). Michael Torres (CEO), Zhiqiang An, and Kyoji Tsuchikama are the co-founders of the company. CrossBridge Bio specializes in the development of antibody-drug conjugates (ADCs) that leverage proprietary linker technology to enhance the stability and effectiveness of cancer therapeutics. The company’s core products include a unique enzymatically cleavable linker known as EGCit (GluGlyCit) and branched linkers conjugated to human IgG1 antibodies through microbial transglutaminase (mTG). This technology enables the production of uniform ADCs with controlled drug-to-antibody ratios (DAR), focusing on providing targeted drug delivery systems for oncology-focused pharmaceutical companies and research institutions, primarily in North America and Europe. CrossBridge Bio's revenue model revolves around partnerships with pharmaceutical and biotechnology companies, offering ADC technology and development services. Revenue is generated through contract agreements that include payments and royalties based on commercialization.
Who invested in CrossBridge Bio
5 investors across 1 round
See all investors in CrossBridge Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 29, 2024
Amount
$11M
Investors
Questions about CrossBridge Bio
Who invested in CrossBridge Bio?
CrossBridge Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CrossBridge Bio raised?
CrossBridge Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CrossBridge Bio last raise money?
CrossBridge Bio's most recent round on record is a Seed, in Oct 2024.
What does CrossBridge Bio do?
Founded in 2023 and based in Texas, US, CrossBridge Bio, Inc.
Where is CrossBridge Bio headquartered?
CrossBridge Bio is headquartered in Houston, US.
Which VCs invest in companies like CrossBridge Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CrossBridge Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CrossBridge Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.